LabCorp expands access to at-home coronavirus testing

By LabPulse.com staff writers

May 12, 2020 -- LabCorp is now opening up its at-home coronavirus molecular diagnostic testing to consumers, having initially offered it to healthcare workers and first responders who may have been exposed.

The Pixel by LabCorp nucleic acid test became the first at-home kit to receive emergency use authorization from the U.S. Food and Drug Administration in April. Using the kit, individuals collect their own nasal samples, with no requirement for an in-person visit to a health professional, minimizing the need for personal protective equipment. Consumers will not have any upfront costs for testing, according to the company.

LabCorp also offers serology testing, which is accessible to consumers through online booking and telemedicine programs, with specimens collected at patient service centers.

LabCorp opens coronavirus antibody test booking to consumers
LabCorp is now offering immunoglobulin G antibody testing directly to individuals through its website LabCorp.com.
AACC warns coronavirus self-tests vulnerable to flawed specimen collection
The American Association for Clinical Chemistry (AACC) has recommended that the U.S. Food and Drug Administration issue a warning about COVID-19 at-home...
White House coronavirus testing blueprint puts states in driver's seat
The White House has released a blueprint for coronavirus testing that outlines the responsibilities of states with support by the federal government,...
LabCorp broadens SARS-CoV-2 serology test availability
LabCorp is expanding access to its serological tests for SARS-CoV-2 to more hospitals and healthcare organizations.
LabCorp wins FDA clearance for at-home COVID-19 test
LabCorp has received emergency use authorization from the U.S. Food and Drug Administration (FDA) for its Pixel by LabCorp COVID-19 at-home test kit....

Copyright © 2020 LabPulse.com

Last Updated ls 5/12/2020 12:48:08 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email